A single-institution, retrospective study determined that having a tangible item improved patient adherence to radiotherapy on-treatment clinic visits.
Compared with patients who undergo surgery alone for abdominal or pelvic cancers, those who receive radiation and chemotherapy are at elevated risk for secondary sarcomas.
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
This study compared body composition, cardiometabolic risk factors, and PS in adult survivors of pediatric abdominal/pelvic tumors with the general US population.
A large cross-sectional cohort study investigated the relationship between hearing loss and measures of neurocognition in survivors of childhood cancers.
Allowing an approximately 24-month recovery period after prostate surgery before giving radiation therapy may be optimal for preserving erectile function provided oncologic control is not compromised, according to investigators.
MASCC/ISOO Mucositis Guidelines Leadership Group released updated recommendations and suggestions for preventing and treating oral mucositis in patients undergoing cancer treatment.
Radiation therapy for higher-risk prostate cancer can be delayed for up to 6 months following initiation of hormonal therapy without incurring a greater mortality risk, a finding that has implications for patient care during the COVID-19 pandemic.
Findings from a recent study support pretreatment screening for heart disease in patients with newly diagnosed, locoregional esophageal cancer.
Injection of a hydrogel spacer to provide prostate-rectum separation during radiation therapy for prostate cancer is associated with decreased radiation-induced rectal toxic effects, according to a new systematic review and meta-analysis.
